Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure 
New Orleans Immigration Crackdown Sparks Fear as Federal Arrests Intensify 
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement 
Israel Receives Body of Deceased Hostage as Rafah Crossing Reopening Hinges on Final Returns 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
U.S. Repatriation Flight Carrying 266 Venezuelan Migrants Lands in Caracas 
U.S.-Russia Talks Leave Ukraine Peace Efforts Uncertain 
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative 
Germany Moves to Approve €2.9 Billion Defense Procurement Package 
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate 
Trump’s Name Appears on U.S. Institute of Peace Ahead of Rwanda–Congo Deal Signing 
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths 
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand 
U.S.–Russia Peace Talks Stall as Kremlin Rejects Key Proposals 
Senators Warn Trump Against Unauthorized Venezuela Strike, Vow War Powers Push 
The White House has no immediate plans to require insurance companies to cover in vitro fertilization (IVF), despite U.S. President Donald Trump’s campaign pledge to expand access to fertility treatments, according to The Washington Post.
Earlier this year, President Trump signed an executive order aimed at expanding IVF access and reducing treatment costs for Americans seeking fertility care. The order directed federal agencies to find ways to make the popular treatment more affordable and accessible. However, White House officials say legal constraints prevent them from mandating insurance coverage without Congressional approval.
While the administration maintains that increasing IVF access is still a policy priority, no legislation has been introduced in Congress to address the insurance coverage gap. Without such a bill, the federal government cannot compel private insurers to include IVF in their health plans.
IVF has become an increasingly sought-after solution for couples and individuals facing infertility, but the high cost—often exceeding $15,000 per cycle in the U.S.—remains a major barrier. Advocates argue that insurance mandates could help millions access treatment, while opponents cite concerns over cost implications for the healthcare system.
The issue has drawn renewed national attention following several state-level legislative battles over fertility treatment access. In some states, lawmakers have moved to protect or expand IVF coverage, while others have faced legal and political challenges that could limit availability.
Reuters was unable to independently verify the Washington Post report, and the White House did not respond to a request for comment. For now, the future of federally mandated IVF insurance coverage remains uncertain, leaving millions of hopeful parents in limbo as the debate over fertility rights and healthcare policy continues.
